We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
-13.89%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$744M
AUM Growth
-$81.5M
Cap. Flow
+$46.5M
Cap. Flow %
6.24%
Top 10 Hldgs %
31.55%
Holding
2,869
New
240
Increased
1,414
Reduced
721
Closed
181

Sector Composition

Rank Sector Weight
1 Technology 12.36%
2 Healthcare 7.65%
3 Financials 6.69%
4 Consumer Staples 6.68%
5 Consumer Discretionary 5.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVOP
2301
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$2K ﹤0.01%
71
-8
-10% -$182
PING
2302
DELISTED
Ping Identity Holding Corp.
PING
$2K ﹤0.01%
107
+7
+7% +$156
FMTX
2303
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$2K ﹤0.01%
+245
New +$1.72K
TMX
2304
DELISTED
Terminix Global Holdings, Inc.
TMX
$2K ﹤0.01%
60
TPTX
2305
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$2K ﹤0.01%
+24
New +$1.07K
NP
2306
DELISTED
Neenah, Inc. Common Stock
NP
$2K ﹤0.01%
55
-257
-82% -$9.61K
TTP
2307
DELISTED
TORTOISE PIPELINE & ENERGY FUND, INC.
TTP
$2K ﹤0.01%
71
ESTE
2308
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
$2K ﹤0.01%
+125
New +$1.97K
ACAD icon
2309
Acadia Pharmaceuticals
ACAD
$4.25B
$1K ﹤0.01%
66
-44
-40% -$821
ACCO icon
2310
Acco Brands
ACCO
$369M
$1K ﹤0.01%
104
-88
-46% -$641
ACRS icon
2311
Aclaris Therapeutics
ACRS
$730M
$1K ﹤0.01%
84
ALGM icon
2312
Allegro MicroSystems
ALGM
$8.58B
$1K ﹤0.01%
36
+28
+350% +$668
ALX
2313
Alexander's
ALX
$1.4B
$1K ﹤0.01%
4
AM icon
2314
Antero Midstream
AM
$10.8B
$1K ﹤0.01%
149
+55
+59% +$572
ANIK icon
2315
Anika Therapeutics
ANIK
$199M
$1K ﹤0.01%
+29
New +$647
ANIP icon
2316
ANI Pharmaceuticals
ANIP
$1.77B
$1K ﹤0.01%
43
+14
+48% +$404
APPF icon
2317
AppFolio
APPF
$5.85B
$1K ﹤0.01%
8
+6
+300% +$605
APPN icon
2318
Appian
APPN
$1.74B
$1K ﹤0.01%
11
+6
+120% +$302
ARRY icon
2319
Array Technologies
ARRY
$818M
$1K ﹤0.01%
93
+24
+35% +$237
AVIR icon
2320
Atea Pharmaceuticals
AVIR
$379M
$1K ﹤0.01%
+130
New +$887
AVNS icon
2321
Avanos Medical
AVNS
$1.17B
$1K ﹤0.01%
53
-12
-18% -$345
AWI icon
2322
Armstrong World Industries
AWI
$6.86B
$1K ﹤0.01%
+15
New +$1.27K
AZEK
2323
DELISTED
The AZEK Co
AZEK
$1K ﹤0.01%
64
+3
+5% +$62
BATRA icon
2324
Atlanta Braves Holdings Series A
BATRA
$3.53B
$1K ﹤0.01%
23
BKD icon
2325
Brookdale Senior Living
BKD
$3.62B
$1K ﹤0.01%
202

Similar funds

Quadrant Capital Group's Q2 2022 Portfolio in Review

As of Q2 2022, Quadrant Capital Group held 2,869 positions worth $744M, down 9.9% from $826M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Quadrant Capital Group deployed $46.5M of net new capital in Q2 2022, opening 240 new positions and adding to 1,414 existing holdings. Its largest new stake was Vanguard Intermediate-Term Bond ETF: 21,020 shares worth $1.63M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Vanguard Short-Term Bond ETF, an estimated $4.02M trimmed.

  • Quadrant Capital Group's largest Q2 2022 buy was Vanguard Intermediate-Term Bond ETF: 21,020 shares worth $1.63M.
  • Quadrant Capital Group added most to iShares Core MSCI EAFE ETF in Q2 2022, an estimated $7.4M increase.
  • Quadrant Capital Group's biggest Q2 2022 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $4.02M.
  • Quadrant Capital Group fully exited RiverNorth Opportunistic Municipal Income Fund in Q2 2022, selling an estimated $900K.
  • Quadrant Capital Group's ten largest holdings make up 32% of its $744M portfolio in Q2 2022.
  • Quadrant Capital Group opened 240 new positions and closed 181 in Q2 2022.
  • Quadrant Capital Group's portfolio value fell 9.9% quarter-over-quarter to $744M.

Based on Quadrant Capital Group's 13F filing for Q2 2022, filed 9 Aug 2022.